Alsugair, A., Fathima, S., Aperna, F., Gangat, N. and Tefferi, A. (2025) “Sodium-glucose co-transporter-2 inhibitor treatmentassociated changes in hemoglobin level in anemic patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms”, Haematologica. Pavia, Italy, 110(6), pp. 1422-1425. doi: 10.3324/haematol.2024.287032.